Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.
CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid
Massachusetts-based target company specialises in rare blood disorders | Deal gives Novo Nordisk access to lead development candidate, etavopivat.
Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs.
New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team.
Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.
O’Melveny has hired life sciences patent litigator Gregory Morris for its New York office as a partner in its IP and technology practice group.
Pharma company facing lawsuit from two universities | Dispute centres on therapeutically effective co-crystals patent.
Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.